Research News on Screening and Testing
-
Many High-Risk Women May Not Be Referred for Genetic Testing
A study suggests that primary care doctors don't consistently recommend genetic testing for women at high-risk for cancer because of family and personal history.
-
Women’s Health Specialists Say Mammograms Should Start at 40
The American College of Obstetricians and Gynecologists has issued new guidelines calling for screening mammograms to start at age 40 for women with average breast cancer risk.
-
Researchers Recommend Regularly Updating Family History of Cancer
A new study found that doctors and patients need to regularly talk about and update the patient's family history of cancer -- including breast cancer.
-
Regular Screening Mammograms Save Lives
A large, long-term Swedish study found that regular screening mammograms reduced a woman's risk of dying of breast cancer by 31%.
-
FDA Approves New HER2 Test
The FDA has approved a new test to determine the HER2 status of breast cancers.
-
High C-Reactive Protein Levels May Influence Prognosis
Research suggests that C-reactive protein levels may be linked to prognosis after a breast cancer diagnosis.
-
FDA Says Thermography Shouldn’t Be Substituted for Mammograms
The FDA has warned that thermography should not be substituted for mammography.
-
Experimental Genomic Test May Help Determine Need for Chemo Before Surgery
An experimental genomic test may help doctors figure out if invasive HER2-negative breast cancer will respond to chemotherapy before surgery.
-
Research Supports Value of Screening Mammograms Starting at 40
Two new studies underscore the value of annual screening mammograms starting at age 40.
-
Genetic Testing of Breast Milk May Help Determine Risk
A small, very early study suggests that doing genetic testing on breast milk could help identify women with breast cancer and women at high risk for breast cancer.
